The Journal of Pediatrics
Volume 157, Issue 2 , Pages 296-302 , August 2010

Infantile Hypercalcemia and Hypercalciuria: New Insights into a Vitamin D-Dependent Mechanism and Response to Ketoconazole Treatment

  • Minh Nguyen, PhD

      Affiliations

    • Inserm U561, Hôpital St Vincent de Paul, Paris, France
    • ,
  • Henri Boutignon, MD

      Affiliations

    • Department of Neonatalogy, Centre Hospitalier, Compiègne, France
    • ,
  • Eric Mallet, MD, PhD

      Affiliations

    • Department of Pediatrics, Centre Hospitalier Universitaire, Rouen, France
    • ,
  • Agnes Linglart, MD, PhD

      Affiliations

    • Department of Pediatric Endocrinology, Hôpital St Vincent de Paul, Paris, France
    • ,
  • Huguette Guillozo

      Affiliations

    • Inserm U561, Hôpital St Vincent de Paul, Paris, France
    • ,
  • Frederic Jehan, PhD

      Affiliations

    • Inserm U561, Hôpital St Vincent de Paul, Paris, France
    • ,
  • Michele Garabedian, MD, PhD

      Affiliations

    • Inserm U561, Hôpital St Vincent de Paul, Paris, France
    • Corresponding Author InformationReprint requests: Michele Garabedian, INSERM U561, Hôpital St Vincent de Paul, 82 Avenue Denfert-Rochereau, 75014 Paris, France.

Received 27 October 2009 ,Revised 5 January 2010 ,Accepted 18 February 2010.

References 

  1. Finne PH, Sanderud J, Aksnes L, Bratlid D, Aarskog D. Hypercalcemia with increased and unregulated 1,25-dihydroxyvitamin D production in a neonate with subcutaneous fat necrosis. J Pediatr. 1988;112:792–794
  2. Garabedian M, Jacqz E, Guillozo H, Grimberg R, Guillot M, Gagnadoux MF, et al. Elevated plasma 1,25-dihydroxyvitamin D concentrations in infants with hypercalcemia and an elfin facies. N Engl J Med. 1985;312:948–952
  3. Stapleton T, MacDonald WB, Lightwood R. The pathogenesis of idiopathic hypercalcemia in infancy. Am J Clin Nutr. 1957;5:533–542
  4. Payne WW. The blood chemistry in idiopathic hypercalcemia. Arch Dis Child. 1952;27:302
  5. Forfar JO, Tompsett SL, Forshall W. Biochemical studies in idiopathic hypercalcaemia of infancy. Arch Dis Child. 1959;34:525–537
  6. Mizusawa Y, Burke JR. Prednisolone and cellulose phosphate treatment in idiopathic infantile hypercalcaemia with nephrocalcinosis. J Paediatr Child Health. 1996;32:350–352
  7. Alon U, Berkowitz D, Berant M. Idiopathic infantile hypercalcemia: rapid response to treatment with calcitonin. Child Nephrol Urol. 1992;12:47–50
  8. Bereket A, Erdogan T. Oral bisphosphonate therapy for vitamin D intoxication of the infant. Pediatrics. 2003;111:899–901
  9. Glass AR, Eil C. Ketoconazole-induced reduction in serum 1,25-dihydroxyvitamin D and total serum calcium in hypercalcemic patients. J Clin Endocrinol Metab. 1988;66:934–938
  10. Saggese G, Bertelloni S, Baroncelli GI, Di Nero G. Ketoconazole decreases the serum ionized calcium and 1,25-dihydroxyvitamin D levels in tuberculosis-associated hypercalcemia. Am J Dis Child. 1993;147:270–273
  11. Adams JS, Sharma OP, Diz MM, Endres DB. Ketoconazole decreases the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia. J Clin Endocrinol Metab. 1990;70:1090–1095
  12. Mc Taggart SJ, Craig J, MacMillan J, Burke JR. Familial occurrence of idiopathic infantile hypercalcemia. Pediatr Nephrol. 1999;13:668–671
  13. Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Roseblatt KP, et al. Regulation of fibroblast growth factor-23 signaling by Klotho. J Biol Chem. 2006;281:6120–6123
  14. Ohnishi M, Nakatani T, Lanske B, Razzaque MS. Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase. Kidney Int. 2009;75:1166–1172
  15. Yoshida T, Fujimori T, Nabeshima YI. Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1alpha-hydroxylase gene. Endocrinology. 2002;143:683–689
  16. Lopez ER, Zwermann O, Segni M, Meyer G, Reincke M, Seissler J, et al. A promoter polymorphism of the CYP27B1 gene is associated with Addison's disease, Hashimoto's thyroiditis, Graves' disease and type 1 diabetes mellitus in Germans. Eur J Endocrinol. 2004;151:193–197
  17. Holick CN, Stanford JL, Kwon EM, Ostrander EA, Nejentsev S, Peters U. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1 and CYP24A1 in prostate cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:1990–1999
  18. d'Alesio A, Garabédian M, Sabatier JP, Guaydier-Souquières G, Marcelli C, Lemaçon A, et al. Two single-nucleotide polymorphisms in the human vitamin D receptor promoter change protein-DNA complex formation and are associated with height and vitamin D status in adolescent girls. Hum Mol Genet. 2005;14:3539–3548
  19. Arking DE, Krebsova A, Macek M, Macek M, Arking A, Mian IS, et al. Association of human aging with a functional variant of klotho. Proc Natl Acad Sci U S A. 2002;99:856–861
  20. Kawano K, Ogata N, Chiano M, Molloy H, Kleyn P, Spector TD, et al. Klotho gene polymorphisms associated with bone density of aged postmenopausal women. J Bone Miner Res. 2002;17:1744–1751
  21. Carter GD, Carter CR, Gunter E, Jones J, Jones G, Makin HL, et al. Measurement of Vitamin D metabolites: an international perspective on methodology and clinical interpretation. J Steroid Biochem Mol Biol. 2004;89-90:467–471
  22. Shepard RM, Horst RL, Hamstra AJ, DeLuca HF. Determination of vitamin D and its metabolites in plasma from normal and anephric man. Biochem.J. 1979;185:55–69
  23. Nguyen TM, Guillozo H, Garabedian M, Mallet E, Balsan S. Serum concentration of 24, 25-dihydroxyvitamin D in normal children and in children with rickets. Pediatr Res. 1979;13:973–976
  24. Nguyen TM, Adiceam P, Kottler ML, Guillozo H, Rizk-Rabin M, Brouillard F, et al. Tryptophan missense mutation in the ligand-binding domain of the vitamin D receptor causes severe resistance to 1,25-dihydroxyvitamin D. J Bone Miner Res. 2002;17:1728–1737
  25. Nguyen TM, Lieberherr M, Fritsch J, Guillozo H, Alvarez ML, Fitouri Z, et al. The rapid effects of 1,25-dihydroxyvitamin D3 require the vitamin D receptor and influence 24-hydroxylase activity. J Biol Chem. 2004;279:7591–7597
  26. Suarez F, Zeghoud F, Rossignol C, Walrant O, Garabedian M. Association between vitamin D receptor gene polymorphism and sex-dependent growth during the first two years of life. J Clin Endocrinol Metab. 1997;82:2966–2970
  27. Adams JS, Singer FR, Gacad MA, Sharma OP, Hayes MJ, Vouros P, et al. Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis. J Clin Endocrinol Metab. 1985;60:960–966
  28. Cadranel J, Hance AJ, Milleron B, Paillard F, Akoun G, Garabedian M. Vitamin D metabolism in tuberculosis: production of 1,25-(OH)2D3 by cells recovered by bronchoalveolar lavage and the role of this metabolite in calcium homeostasis. Am Rev Resp Dis. 1988;138:984–989
  29. Weisman Y, Harell A, Edelstein S. Infantile hypercalcemia: a defect in the esterification of 1,25-dihydroxyvitamin D?. Med Hypotheses. 1979;5:379–382
  30. Vervel C, Zeghoud F, Boutignon H, Tjani JC, Walrant-Debray O, Garabedian M. Fortified milk and oral daily supplements of vitamin D. Comparison of the effects of two doses (500 and 1,000 IU/d) on calcium metabolism and vitamin D status during the first trimester of life. Arch Pediatr. 1997;4:126–132

 The authors declare no conflicts of interest.

PII: S0022-3476(10)00149-6

doi: 10.1016/j.jpeds.2010.02.025

The Journal of Pediatrics
Volume 157, Issue 2 , Pages 296-302 , August 2010

Article Tools

* Image Usage & Resolution